Wspólnotowy Serwis Informacyjny Badan i Rozwoju - CORDIS


SCAVIDIN Streszczenie raportu

Project ID: QLK3-CT-2001-02166
Źródło dofinansowania: FP5-LIFE QUALITY
Kraj: Finland

Targeted gene and drug delivery system

We have developed a new targeted gene and drug delivery platform technology which is based on the high affinity binding of avidin to biotin. Avidin fusion protein is delivered to target cells (i.g. tumors) by local gene transfer. The Scavidin system will be potentially useful for targeted therapy for malignant glioma and other serious diseases. Scavidin may also be useful for in vivo imaging purposes and in studies related to biotin metabolism and functions.

Powiązane informacje

Reported by

University of Kuopio, A.I.Virtanen Institute
P.O.Box 1627
70211 Kuopio
See on map
Śledź nas na: RSS Facebook Twitter YouTube Zarządzany przez Urząd Publikacji UE W górę